Filters
Rheumatic and musculoskeletal diseases (RMD) may negatively impact sexual well-being, a study suggests.
A short-term intervention combining sleep scheduling and use of bright-light glasses in the morning and blue light–blocking glasses in the evening can correct the circadian timing and extend weeknight sleep duration in adolescents, as shown in a study.
Individuals with insomnia with short sleep duration are at heightened risk of cardiovascular disease (CVD) and cerebrovascular disease (CBVD), according to a study.
Individuals with low income or high BMI appear to be more vulnerable to heatwaves, while those with low income or normal BMI tend to have greater sensitivity during cold spells, both of which contribute to fewer daily step counts, suggests a study.
Individuals with coeliac disease have about a threefold increased likelihood of solid organ transplantation, according to a study.
Local research has shown measuring brain-derived p-tau217 in blood has superior accuracy than measuring other p-tau species for detecting Alzheimer’s disease (AD)-related amyloid pathology in older adults in Singapore.
A higher arousal threshold is associated with a more severe hypoxic burden in patients with obstructive sleep apnea (OSA) but shows a nonlinear correlation with apnea-hypopnea index (AHI), reveals a study.
The use of low-dose rivaroxaban among patients with advanced chronic kidney disease (CKD) and high cardiovascular (CV) risk does little to reduce the risk of adverse CV events and may even contribute to increased bleeding events, according to the TRACK randomized clinical trial.
In the treatment of patients with unresectable embolization-eligible hepatocellular carcinoma (eeHCC), combining transarterial chemoembolization (TACE) with the immunotherapy-based STRIDE (single tremelimumab regular interval durvalumab) regimen with or without lenvatinib substantially increases progression-free survival (PFS), as shown in the global phase 3 EMERALD-3 study.
Immunotherapy directed at desmocollin-3 (DSC3) safely improves outcomes in patients with recurrent or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC) expressing DSC3, reports a study presented at ASCO 2026.
